Emletra Junior 25 mg/100 mg Tablet
Prescription Required
Introduction of Emletra Junior Tablet
Emletra Junior 25 mg/100 mg Tablet is a combination of antiretrovirals medicines. It is prescribed to treat HIV (human immunodeficiency virus) infection. It boosts up the immunity to fight against HIV to manage or treat AIDS (acquired immunodeficiency syndrome).
Emletra Junior 25 mg/100 mg Tablet is a combination of two anti-HIV medicines: Emletra Junior 25 mg/100 mg Tablet1 and Emletra Junior 25 mg/100 mg Tablet2.
Emletra Junior 25 mg/100 mg Tablet is a combination of two anti-HIV medicines: Emletra Junior 25 mg/100 mg Tablet1 and Emletra Junior 25 mg/100 mg Tablet2.
Uses of Emletra Junior Tablet
Benefits of Emletra Junior Tablet
In HIV infection
Emletra Junior 25 mg/100 mg Tablet prevents the HIV virus from multiplying in your body. It helps control the infection and makes your immune system work better. This lowers your chances of getting complications such as new infections and improves your quality of life.
It is not a cure of HIV or AIDS and should not be used to prevent HIV after accidental exposure to a risk. It is important that you take this medicine as prescribed, following the dosage recommended by your doctor. Taking all doses in the right amount at the right times greatly increases the effectiveness of your combination of medicines and reduces the chances of your HIV infection becoming resistant to antiretroviral medicines. However, taking this medicine will not prevent you from passing HIV to other people.
It is not a cure of HIV or AIDS and should not be used to prevent HIV after accidental exposure to a risk. It is important that you take this medicine as prescribed, following the dosage recommended by your doctor. Taking all doses in the right amount at the right times greatly increases the effectiveness of your combination of medicines and reduces the chances of your HIV infection becoming resistant to antiretroviral medicines. However, taking this medicine will not prevent you from passing HIV to other people.
Side effects of Emletra Junior Tablet
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Emletra Junior
- Taste change
- Headache
- Nausea
- Vomiting
- Diarrhea
- Stomach pain
- Increased liver enzymes
- Increased blood lipid level
- Peripheral neuropathy (tingling and numbness of feet and hand)
How to use Emletra Junior Tablet
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Emletra Junior 25 mg/100 mg Tablet is to be taken with food.
Safety advice
Alcohol
CAUTION
Caution is advised when consuming alcohol with Emletra Junior 25 mg/100 mg Tablet. Please consult your doctor.
Pregnancy
CONSULT YOUR DOCTOR
Emletra Junior 25 mg/100 mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding
SAFE IF PRESCRIBED
Emletra Junior 25 mg/100 mg Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Driving
CONSULT YOUR DOCTOR
It is not known whether Emletra Junior 25 mg/100 mg Tablet alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.
Kidney
SAFE IF PRESCRIBED
Emletra Junior 25 mg/100 mg Tablet is probably safe to use in patients with kidney disease. Limited data available suggests that dose adjustment of Emletra Junior 25 mg/100 mg Tablet may not be needed in these patients. Please consult your doctor.
Liver
CAUTION
Emletra Junior 25 mg/100 mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Emletra Junior 25 mg/100 mg Tablet may be needed. Please consult your doctor.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
No substitutes found for this medicine
Quick tips
Emletra Junior Tablet
- Emletra Junior 25 mg/100 mg Tablet is a combination medicine which slows down or stops the progression of HIV infection in the body.
- Take it with food, preferably at the same time each day.
- Skipping doses increases the risk of treatment failure. Make sure that you take all your doses at the correct time.
- It may cause weight gain and weakening of your bones. Eat healthy, exercise regularly and take calcium and vitamin D supplements as suggested by your doctor.
- It may cause dizziness and sleepiness. Don't drive or do anything that requires mental focus until you know how it affects you.
- Your doctor may monitor your kidney and liver functions regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, darkened urine or yellowing of the eyes or skin.
- Do not stop taking Emletra Junior 25 mg/100 mg Tablet without your doctor’s advice.
Fact Box
Habit Forming
No
Therapeutic Class
ANTI INFECTIVES
Patient concerns
Patient concerns
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Ciplamed. Ritonavir+Lopinavir. [Accessed on 10 Apr. 2019 ] (online) Available from:
- Ritonavir+Lopinavir. North Chicago, Illinois: Abbott Laboratories; 2010. [Accessed 10 Apr. 2019] (online) Available from:
- Ritonavir/Lopinavir. Maidenhead, Berkshire: AbbVie Ltd.; 2001 [revised 25 Oct. 2018]. [Accessed 10 Apr. 2019] (online) Available from:
- Ritonavir+Lopinavir. Barceloneta, Puerto Rico: AbbVie Ltd.; 2000 [revised Nov. 2016]. [Accessed 10 Apr. 2019] (online) Available from:
Marketer details
Name: Emcure Pharmaceuticals Ltd
Address: 255/2, Hinjawadi, Pune - 411057, India
Country of origin: India
Lab tests offered by us
Related/Popular tests
77 people viewed this recentlyMRP
₹1475.47
Inclusive of all taxes
60.0 tablets in 1 bottle
SOLD OUT
Notify me